277 related articles for article (PubMed ID: 23977065)
21. Recombinant parainfluenza virus 5 vaccine encoding the influenza virus hemagglutinin protects against H5N1 highly pathogenic avian influenza virus infection following intranasal or intramuscular vaccination of BALB/c mice.
Mooney AJ; Li Z; Gabbard JD; He B; Tompkins SM
J Virol; 2013 Jan; 87(1):363-71. PubMed ID: 23077318
[TBL] [Abstract][Full Text] [Related]
22. Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice.
Takada A; Matsushita S; Ninomiya A; Kawaoka Y; Kida H
Vaccine; 2003 Jul; 21(23):3212-8. PubMed ID: 12804850
[TBL] [Abstract][Full Text] [Related]
23. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells.
Throsby M; van den Brink E; Jongeneelen M; Poon LL; Alard P; Cornelissen L; Bakker A; Cox F; van Deventer E; Guan Y; Cinatl J; ter Meulen J; Lasters I; Carsetti R; Peiris M; de Kruif J; Goudsmit J
PLoS One; 2008; 3(12):e3942. PubMed ID: 19079604
[TBL] [Abstract][Full Text] [Related]
24. Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model.
Liu WC; Nachbagauer R; Stadlbauer D; Solórzano A; Berlanda-Scorza F; García-Sastre A; Palese P; Krammer F; Albrecht RA
Front Immunol; 2019; 10():756. PubMed ID: 31105689
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the Immune Responses to and Cross-Protective Efficacy of Eurasian H7 Avian Influenza Viruses.
Kwon HI; Kim YI; Park SJ; Song MS; Kim EH; Kim SM; Si YJ; Lee IW; Song BM; Lee YJ; Yun SJ; Kim WJ; Choi YK
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331080
[TBL] [Abstract][Full Text] [Related]
26. Extending the Stalk Enhances Immunogenicity of the Influenza Virus Neuraminidase.
Broecker F; Zheng A; Suntronwong N; Sun W; Bailey MJ; Krammer F; Palese P
J Virol; 2019 Sep; 93(18):. PubMed ID: 31375573
[TBL] [Abstract][Full Text] [Related]
27. Monoclonal Antibody Responses after Recombinant Hemagglutinin Vaccine versus Subunit Inactivated Influenza Virus Vaccine: a Comparative Study.
Henry C; Palm AE; Utset HA; Huang M; Ho IY; Zheng NY; Fitzgerald T; Neu KE; Chen YQ; Krammer F; Treanor JJ; Sant AJ; Topham DJ; Wilson PC
J Virol; 2019 Nov; 93(21):. PubMed ID: 31434733
[TBL] [Abstract][Full Text] [Related]
28. A broadly neutralizing human monoclonal antibody directed against a novel conserved epitope on the influenza virus H3 hemagglutinin globular head.
Benjamin E; Wang W; McAuliffe JM; Palmer-Hill FJ; Kallewaard NL; Chen Z; Suzich JA; Blair WS; Jin H; Zhu Q
J Virol; 2014 Jun; 88(12):6743-50. PubMed ID: 24696468
[TBL] [Abstract][Full Text] [Related]
29. Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine.
Corti D; Suguitan AL; Pinna D; Silacci C; Fernandez-Rodriguez BM; Vanzetta F; Santos C; Luke CJ; Torres-Velez FJ; Temperton NJ; Weiss RA; Sallusto F; Subbarao K; Lanzavecchia A
J Clin Invest; 2010 May; 120(5):1663-73. PubMed ID: 20389023
[TBL] [Abstract][Full Text] [Related]
30. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
Walz L; Kays SK; Zimmer G; von Messling V
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
[TBL] [Abstract][Full Text] [Related]
31. Baculovirus Displaying Hemagglutinin Elicits Broad Cross-Protection against Influenza in Mice.
Sim SH; Kim JY; Seong BL; Nguyen HH; Chang J
PLoS One; 2016; 11(3):e0152485. PubMed ID: 27023684
[TBL] [Abstract][Full Text] [Related]
32. Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine.
Johansson BE
Vaccine; 1999 Apr; 17(15-16):2073-80. PubMed ID: 10217609
[TBL] [Abstract][Full Text] [Related]
33. Administration of Multivalent Influenza Virus Recombinant Hemagglutinin Vaccine in Combination-Adjuvant Elicits Broad Reactivity Beyond the Vaccine Components.
Hernandez-Davies JE; Felgner J; Strohmeier S; Pone EJ; Jain A; Jan S; Nakajima R; Jasinskas A; Strahsburger E; Krammer F; Felgner PL; Davies DH
Front Immunol; 2021; 12():692151. PubMed ID: 34335601
[TBL] [Abstract][Full Text] [Related]
34. L226Q Mutation on Influenza H7N9 Virus Hemagglutinin Increases Receptor-Binding Avidity and Leads to Biased Antigenicity Evaluation.
Wang Y; Lv Y; Niu X; Dong J; Feng P; Li Q; Xu W; Li J; Li C; Li J; Luo J; Li Z; Liu Y; Tan YJ; Pan W; Chen L
J Virol; 2020 Sep; 94(20):. PubMed ID: 32796071
[TBL] [Abstract][Full Text] [Related]
35. Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses.
Margine I; Krammer F; Hai R; Heaton NS; Tan GS; Andrews SA; Runstadler JA; Wilson PC; Albrecht RA; García-Sastre A; Palese P
J Virol; 2013 Oct; 87(19):10435-46. PubMed ID: 23903831
[TBL] [Abstract][Full Text] [Related]
36. An Improved Inactivated Influenza Vaccine with Enhanced Cross Protection.
Ni Y; Guo J; Turner D; Tizard I
Front Immunol; 2018; 9():1815. PubMed ID: 30140267
[TBL] [Abstract][Full Text] [Related]
37. Cross-protective efficacy of baculovirus displayed hemagglutinin against highly pathogenic influenza H7 subtypes.
Prabakaran M; Kumar SR; Raj KV; Wu X; He F; Zhou J; Kwang J
Antiviral Res; 2014 Sep; 109():149-59. PubMed ID: 24997413
[TBL] [Abstract][Full Text] [Related]
38. IgA polymerization contributes to efficient virus neutralization on human upper respiratory mucosa after intranasal inactivated influenza vaccine administration.
Terauchi Y; Sano K; Ainai A; Saito S; Taga Y; Ogawa-Goto K; Tamura SI; Odagiri T; Tashiro M; Fujieda M; Suzuki T; Hasegawa H
Hum Vaccin Immunother; 2018 Jun; 14(6):1351-1361. PubMed ID: 29425074
[TBL] [Abstract][Full Text] [Related]
39. Recombinant influenza H1, H5 and H9 hemagglutinins containing replaced H3 hemagglutinin transmembrane domain showed enhanced heterosubtypic protection in mice.
Liu Q; Liu K; Xue C; Zhou J; Li X; Luo D; Zheng J; Xu S; Liu GD; Cao Y
Vaccine; 2014 May; 32(25):3041-9. PubMed ID: 24704333
[TBL] [Abstract][Full Text] [Related]
40. Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice.
Wohlbold TJ; Chromikova V; Tan GS; Meade P; Amanat F; Comella P; Hirsh A; Krammer F
J Virol; 2016 Jan; 90(2):851-61. PubMed ID: 26512088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
